Latest News

Rogue breast tumor proteins point to potential drug therapies

For patients with difficult-to-treat cancers, doctors increasingly rely on genomic testing of tumors to identify errors in the DNA that indicate a tumor can be targeted by existing therapies. But this approach overlooks another potential…

Eberlein testifies in support of medical research funding

Federal funding is critical to the search for innovative therapies for cancer and other diseases, Timothy J. Eberlein, MD, told members of a U.S. Senate subcommittee March 8 in Washington. Support from the National Institutes…

View All News
Request an Appointment